Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2021-02-28
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to explore how the COVID-19 affects chronic pain patients in terms of pain in general, intensity of pain, desire for pain treatment including follow up visits and pain medication refills as well as sleep.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
What are the effects of the COVID-19 on chronic pain patients in terms of pain and pain management?
Conceptual framework
The COVID-19 is a novel emerging infectious disease which has unimaginable and unbelievable large scale distressing effects worldwide.
Up to date, there is no study which aims to evaluate the effects of the COVID-19 on chronic pain patients in terms of pain and pain management. The previous survey in patients focused on the worrisome of them for getting this infection and their confidence in their government to control the COVID-19 situation in the US.
Materials and methods
This study is an in-depth interview. The in-depth interview is the principal method to collect qualitative data by setting up open-ended questions beforehand. Patients who are interviewed, can express their attitudes freely. This method is flexible which words, sentences and questions can be adjusted to suit each interviewee (participant). The process consists of active and intentional listening as well as ask on an in-depth basis. All conversations during the in-depth interview are tape-recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention (only interview)
Interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic pain patients are patients with persistent pain for at least 3 months. Pain can be from any etiologies.
* The expected number of interviwees for this in-depth interview is 30 or until the gathered interview data are saturated.
Exclusion Criteria
* Patients who are not influence in Thai language.
* Patients who are physically or mentally too ill to participate this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prince of Songkla University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sasikaan Nimmaanrat
Primary Investigator, Head of Pain Clinic, Clinical Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sasikaan Nimmaanrat, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Prince of Songkla University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Wolf MS, Serper M, Opsasnick L, O'Conor RM, Curtis L, Benavente JY, Wismer G, Batio S, Eifler M, Zheng P, Russell A, Arvanitis M, Ladner D, Kwasny M, Persell SD, Rowe T, Linder JA, Bailey SC. Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey. Ann Intern Med. 2020 Jul 21;173(2):100-109. doi: 10.7326/M20-1239. Epub 2020 Apr 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC.63-359-8-1
Identifier Type: -
Identifier Source: org_study_id